Jornadas Mediteraneas

 

ISSCA to host regenerative medicine symposium during Jornadas Mediteraneas—Mediterranean Days of Therapeutic Confrontations in Medicine and Cosmetic Surgery—in Barcelona.

MIAMI, April 2, 2018—The International Association for Stem Cell Application (ISSCA) has announced plans to host a regenerative medicine symposium during Jornadas MediteraneasMediterranean Days of Therapeutic Confrontations in Medicine and Cosmetic Surgery— in Barcelona, Spain May 13, 2018.

The ISSCA symposium will provide a platform for Global Stem Cells Group to conduct master classes in digital marketing for aesthetic practices and regenerative medicine, conducted by specialists in these fields.

ISSCA Barcelona Symposium

Benito Novas, Global Stem Cells Group CEO

GSCG CEO Benito Novas will conduct a master class in digital marketing for aesthetic physicians. Novas, a global entrepreneur and medical marketing professional in the fields of biotechnology, life sciences, and healthcare development, will share his expertise and the latest marketing tools for managing an aesthetic medicine practice. Topics will include social media strategies for promoting physician practices, and how to design Google and Facebook ads that generate targeted leads and engage new potential patients.

Novas’s class will provide aesthetic medicine professionals with a valuable opportunity to learn about the most effective marketing resources and methods for growing an aesthetic medicine practice and best practices for managing different advertising resources.

In addition, Novas’s class will offer expert tips for using content marketing strategies to build a practice. Following the class, Novas will launch his newest book, “Marketing Digital en su clinica Estetica”(“Digital Marketing in Your Aesthetics Clinic”) as well as his new online course, “Digital Marketing for Aesthetic Physicians.

Jornadas Mediteraneas

DRA Maritza Novas

The second master class will focus on regenerative medicine and will be split into two sessions, the first of which will be conducted by stem cell specialist DRA Maritza Novas and anti-aging and regenerative medicine specialist Leslie Mesen, M.D.

Novas and Mesen will offer instruction on adult stem cells, which have attracted the attention of scientists and physicians worldwide for their unique biological properties and potential for treating disease, injuries, and medical conditions. Stem cell research is complex and fast-growing, with new developments progressing rapidly.

Novas will share her expertise, experiences, and perspective on a broad range of topics regarding advancements in mesenchymal stem cell (MSC) applications during their transition from bench side to bedside.

Jornadas Mediteraneas

Leslie Mesen, M.D.

The second session will feature Mesen, Medical Director of Stem Cells Costa Rica who is board certified in anti-aging and regenerative medicine by The American Academy of Anti-Aging Medicine, and DRA Mar Vargas, Director of the Lasar Sculpture Medical Clinic in Escazu, Costa Rica, who will present their insights regarding clinical applications of stem cell treatments and share information about their clinical experiences with symposium audience members.

Jornadas Mediteraneas

DRA Mar Vargas, Lasar Sculpture Medical Clinic

Sponsored by ISSCA, the symposium will utilize the Jornadas Mediteraneas platform to continue its mission to support a paradigm shift in healthcare from traditional to regenerative medicine in the 21st Century and provide cutting-edge information on developments in all areas of stem cell research.

To learn more about the symposium and digital marketing masterclass and to make a reservation, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.

About ISSCA:

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training. and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

About Global Stem Cells Group:

Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.

Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.

 

Jornadas Mediteraneas master classes

 

 

 

 

 

 

 

ISSCA Founder and President Daeyong Kim, Ph.D., announces plans to host the Regenerative Medicine Cell Therapies Symposium in Seoul, Korea in November.

MIAMI, April 2, 2018—International Association for Stem Cell Application (ISSCA) President Daeyong Kim, Ph.D., has announced plans to host Applications of Cell Therapies in Medicine and Aesthetic Surgery, a regenerative medicine symposium, in Seoul Korea November 24, 2018.

The symposium will be ISSCA’s principal event for 2018, during which the organization will launch its entire 2019 program, including stem cell certification courses for physicians to be held in locations worldwide, as well as the 2019 regenerative medicine symposium agenda.

In 2019, ISSCA plans to expand its activities to Asia by hosting at least one regenerative medicine symposium and four stem cell certification courses during the year. The Korea symposium will be structured as a scientific meeting in which regenerative medicine practitioners share their clinical experience. ISSCA affiliate Global Stem Cells Group, and biomedical and leading lab equipment manufacturer N-Biotek will launch new technology for regenerative medicine practitioners.

The international symposium is part of ISSCA’s mission to support a paradigm shift in healthcare from traditional to regenerative medicine in the 21st Century and provide cutting-edge information on developments in all areas of stem cell research. The Buenos Aires event will host a group of renowned international speakers in the field of stem cell and regenerative medicine, who will offer a day of rigorous scientific discourse aimed at physicians.

Topics of focus at the symposium include:

  • Management of aging at the cellular level
  • Stem cell therapies in medical aesthetics: the latest methods of harvest and isolation Non-invasive protocols of non-surgical facial and body rejuvenation
  • Beyond fillers and toxins
  • Combined treatment plans that include surgical methods for the management of advanced aging
  • Restoration and assisted hair transplantation with biomaterials and growth factors
  • The invaluable role of biological cosmeceutical in the management of aging
  • The aging process from the inside out: the role of hormones
  • Management of the latest digital marketing tools for recruiting patients in their aesthetic clinics

The symposium will incorporate the biology, medicine, applications, regulations, product development, and commercialization of stem cells. Business opportunities, challenges, and potential strategies for overcoming these challenges will also be addressed.

To learn more about the ISSCA Korea symposium and to make a reservation, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.

About ISSCA:

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training. and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally.  Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

 ISSCA Korea regenerative medicine symposium

cell therapy fellowship

 

 

 

 

 

Image:  Facultad de Medicina – Universidad de Buenos Aires

ISSCA will host Applications of Cell Therapies in Medicine and Aesthetic Surgery, a regenerative medicine symposium in Buenos Aires, Argentina, August 24, 2018.

MIAMI, March 18, 2018—The International Association for Stem Cell Application (ISSCA) has announced plans to host Applications of Cell Therapies in Medicine and Aesthetic Surgery, a regenerative medicine symposium. In Buenos Aires, Argentina August 24, 2018.

The international symposium is part of ISSCA’s mission to support a paradigm shift in healthcare from traditional to regenerative medicine in the 21st Century and provide cutting-edge information on developments in all areas of stem cell research. The Buenos Aires event will host a group of renowned international speakers in the field of stem cell and regenerative medicine, who will offer a day of rigorous scientific discourse aimed at physicians.

Topics of focus at the symposium include:

  • Management of aging at the cellular level
  • Stem cell therapies in medical aesthetics: the latest methods of harvest and isolation Non-invasive protocols of non-surgical facial and body rejuvenation
  • Beyond fillers and toxins
  • Combined treatment plans that include surgical methods for the management of advanced aging
  • Restoration and assisted hair transplantation with biomaterials and growth factors
  • The invaluable role of biological cosmeceutical in the management of aging
  • The aging process from the inside out: the role of hormones
  • Management of the latest digital marketing tools for recruiting patients in their aesthetic clinics

The symposium will incorporate the biology, medicine, applications, regulations, product development, and commercialization of stem cells. Business opportunities, challenges, and potential strategies for overcoming these challenges will also be addressed.

The event will be held at the Facultad de Medicina – Universidad de Buenos Aires

To learn more about the ISSCA Buenos Aires symposium and to make a reservation, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.

About ISSCA:

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training. and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally.  Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

###

ISSCA Buenos Aires Regenerative Medicine Symposium

Daeyong Kim, Ph.D., and Syed Salman Naeem Gilani, M.D.

ISSCA Founder Daeyong Kim, Ph.D., and Syed Salman Naeem Gilani, M.D. to speak at the Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey, April 28, 2018.

MIAMI, March 18, 2018—ISSCA Founder and General Director Daeyong Kim, Ph.D., and Syed Salman Naeem Gilani, M.D. will be keynote speakers at the ISSCA Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey April 28, 2018. Kim will discuss stem cell therapies for diabetes, and Gilani will speak on the effect of autologous bone marrow-derived stem cells treatments on knee osteoarthritis.

advisory board, Global Stem Cells Group

Daeyong Kim, Ph.D.

Kim, a Global Stem Cells Group Advisory Board member, is an internationally recognized health educator, and CEO of N-Biotek, Inc, a preeminent manufacturer of biomedical and laboratory equipment and leader of stem cell technology solutions for providers worldwide.

Additionally, Kim is vice-president of BioChip Society, CEO of GTOP Construction Inc, managing director Woojoo Telecom, and managing director of KEPCO KDN.

In 2013, Kim completed an international business course at UC Berkeley, U.S. and received and an M.D. in alternative medicine at IBAM, India. In 2016, he received a Ph.D. in adipose-derived stem cell research at Westminster University in Korea.

Gilani is the Founder, CEO and Stem Cell/Regenerative Medicine Consultant for The Institute of Regenerative Medicine in Rawalpindi, Pakistan, the first-of-its-kind regenerative medicine institute in Pakistan that caters to clinical applications of stem cell and other regenerative medicine treatments. The institute also serves as a center of excellence in training physicians and paramedic staff in regenerative medicine in Pakistan.

Daeyong Kim, Ph.D., and Syed Salman Naeem Gilani, M.D.

Syed Salman Naeem Gilani, M.D.

In 2000, Gilani received his medical degree from Rawalpindi Medical College, Punjab University and completed a Fellowship in Stem Cell Therapy from the American Board of Anti-aging and Regenerative Medicine. He is ECFMG certified, a member of the American Academy of Anti-Aging and Regenerative Medicine, and a Diplomat of the American Academy of Aesthetic Medicine.

The Istanbul international symposium is part of ISSCA’s mission to support a paradigm shift from traditional healthcare solutions to regenerative medicine and provide the latest innovative discoveries and developments in all areas of stem cell research. The symposium will host a group of renowned international speakers, experts in the field of stem cell and regenerative medicine, who will provide a full day of rigorous scientific discourse directed to physicians.

The day’s events will incorporate information on stem cell biology, medicine, applications, regulations, product development, and commercialization, business opportunities, challenges, and potential strategies for overcoming those challenges.

To participate in the ISSCA Istanbul Symposium, reserve your spot by registering today. For more information, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.
About International Society for Stem Cell Application (ISSCA):

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

###

Daeyong Kim, Ph.D., and Syed Salman Naeem Gilani, M.D.

Daeyong Kim, Ph.D., and Syed Salman Naeem Gilani, M.D.

ISSCA names R. Gökmen Turan M.D., Ph.D., and Mahir Mahirogullari, M.D. keynote speakers at the Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey, April 28, 2018.

MIAMI, March 18, 2018— R. Gökmen Turan M.D., Ph.D. and Mahir Mahirogullari, M.D. will be featured speakers at the ISSCA Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey April 28, 2018. Turan will speak on therapeutic applications of stem cells in heart failure, and Mahirogullari will discuss cartilage treatment combining stem cells and biomedical scaffolds.

R. Gökmen Turan M.D., Ph.D.

R. Gökmen Turan M.D., Ph.D.

Turan is a cardiologist and head of the Structural Heart Disease Department of Internal Medicine, Division of Cardiology at Porz Hospital, University Hospital of Cologne and University of Witten/Herdecke Germany.

Mahirogullari is an orthopedic surgeon specializing in sports medicine and traumatology.  He currently serves as a professor at Memorial Health Group in İstanbul, Turkey.

His focus includes multi-ligament injuries and cartilage repair of the knee; arthroplasty of the knee, hip and shoulder; arthroscopy of the knee, shoulder, hip, ankle and elbow joints; surgery of instability and cuff tear of the shoulder; orthopedic trauma, and the application of platelet-rich plasma (PRP), bone marrow aspirate stem cells and adipose-derived stem cells for treatment of orthopedic pathologies especially cartilage injuries.

Mahir Mahirogullari. M.D.

Mahir Mahirogullari. M.D.

Mahirogullari received his medical degree (M.D.) from Gülhane Military Medical Academy School of Medicine in Ankara, Turkey in 1992 and completed his residency at GATA Haydarpasa Training Hospital in Istanbul.

He served as a general practitioner and orthopedic surgeon, treating and managing multi-trauma patients and war injuries. He also served with KFOR, NATO in Kosovo for six months. He worked as a Fellow with arthroscopic shoulder, knee, and trauma specialist Gary G. Poehling, M.D. in Winston Salem, North Carolina for one year before joining the faculty at Istanbul Medipol University School of Medicine in 2012 as chairman of the Department of Orthopedic Surgery. He has worked within the Memorial Health Group in Istanbul since 2016.

Mahirogullari is a member of The Turkish Society of Orthopedics and Traumatology (TOTBİD), The Turkish Society of Arthroscopy Knee Surgery & Orthopedics Sport Medicine (TUSYAD), The International Society of Arthroscopy Knee Surgery & Orthopedics Sport Medicine (ISAKOS),  The Turkish Society of Shoulder and Elbow Society, The European Society of Sports Traumatology Knee Surgery and Arthroscopy (ESSKA 2000), The Turkish Board Certificate,  and The Turkish Society of Hip and Knee Arthroplasty.

The Istanbul international symposium is part of ISSCA’s mission to support a paradigm shift from traditional healthcare solutions to regenerative medicine and provide the latest innovative discoveries and developments in all areas of stem cell research. The symposium will host a group of renowned international speakers, experts in the field of stem cell and regenerative medicine, who will provide a full day of rigorous scientific discourse directed to physicians.

The day’s events will incorporate information on stem cell biology, medicine, applications, regulations, product development, and commercialization, business opportunities, challenges, and potential strategies for overcoming those challenges.

To participate in the ISSCA Istanbul Symposium, reserve your spot by registering today. For more information, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.
About International Society for Stem Cell Application (ISSCA):

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

###

R. Gökmen Turan M.D., Ph.D. and Mahir Mahirogullari, M.D.

Daeyong Kim, Ph.D., and Syed Salman Naeem Gilani, M.D.

 

 

 

 

 

 

 

ISSCA announces keynote speakers Mehmet Veli Karaaltın, M.D. and Mehmet Bozkurt, M.D. at the Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey, April 28.

MIAMI, March 18, 2018— Mehmet Veli Karaaltın M.D. and Mehmet Bozkurt, M.D. will be featured speakers at the ISSCA Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey April 28, 2018. Karaaltın will speak on the role of cellular therapy and futuristic applications in plastic reconstructive surgery: from anti-aging to reconstructive surgery (level evidence IV). Bozkurt will discuss the application of regenerative cells on immunologic and diabetic wounds and severe burns.

Mehmet Veli Karaaltın M.D. and Mehmet Bozourt, M.D.

Mehmet-Veli-Karaaltın, M.D.

Karaaltın, a Global Stem Cells Group advisory board member, specializes in head and maxillofacial surgery and hand surgery, and serves as an associate professor of plastic aesthetic & reconstructive surgery (European Board Certified) at Hacettepe University Medical Faculty in Ankara, Turkey.

After graduating from Istanbul University’s Cerrahpaşa English Medical Faculty, Karaaltın completed a national examination from Hacettepe University in Ankara, Turkey, placing 12th out of 25,000 doctoral candidates. He later completed all exam requirements of the European Society of Plastic Surgery. He is a member of the European Council of Plastic Reconstructive and Aesthetic Surgery and the International Society of Aesthetic Plastic Surgery (ISAPS).

In addition to his work in aesthetic applications, Karaaltın is also known for his work in microvascular free flaps, nerve transfers, facial surgery, and tissue transplants. He also practices cellular therapy and tissue regeneration for healing diabetic wounds, severe burns, and Buerger’s disease. He is one of only a few physicians in the world who offer surgical treatment for Lymphedema-Elephant Disease with microvascular lymph node transfer.

Mehmet Veli Karaaltın M.D. and Mehmet Bozourt, M.D.

Mehmet Bozkurt, M.D.

Bozkurt is a plastic and reconstructive surgeon and serves as chairman and director of the plastic reconstructive surgery and burn center at Kartal Dr. Lütfi Kırdar Training and Research Hospital in Istanbul. He completed his clinical fellowship in microsurgery at Cleveland Clinic in 2012. Bozkurt is a member of The International Federation for Adipose Therapeutics and Science, The İnternational Society of Burn Association, and The Turkish Aesthetic Surgery Association. He is board certified in European plastic surgery and Turkish plastic surgery.

He completed medical school in July 1995 at the Gulhane Military Medical Academy Faculty of Medicine in Ankara, Turkey and completed post-graduate studies and training in emergency medicine, microsurgery, plastic and reconstructive surgery, orthopedic medicine, and preventative medicine. He is the recipient of numerous honors and awards in his field.

The Istanbul international symposium is part of ISSCA’s mission to support a paradigm shift from traditional healthcare solutions to regenerative medicine and provide the latest innovative discoveries and developments in all areas of stem cell research. The symposium will host a group of renowned international speakers, experts in the field of stem cell and regenerative medicine, who will provide a full day of rigorous scientific discourse directed to physicians.

The day’s events will incorporate information on stem cell biology, medicine, applications, regulations, product development, and commercialization, business opportunities, challenges, and potential strategies for overcoming those challenges.

To participate in the ISSCA Istanbul Symposium, reserve your spot by registering today. For more information, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.

About International Society for Stem Cell Application (ISSCA):

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

###

Mehmet Veli Karaaltın M.D. and Mehmet Bozourt, M.D.

Daeyong Kim, Ph.D., and Syed Salman Naeem Gilani, M.D.

 

 

 

 

 

 

 

ISSCA announces keynote speakers Abdul Majeed, M.D. and Hilmi Karadeniz, M.D. at the Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey, April 28, 2018.

MIAMI, March 18, 2018—Abdul Majeed, M.D. and Hilmi Karadeniz, M.D. will be featured speakers at the ISSCA Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey April 28, 2018. Majeed will discuss findings of a recent study on intra-arterial injection of autologous bone marrow-derived mononuclear cells in ischemic stroke patients. Karadeniz will speak on current approaches to the application of regenerative treatments in athletes.

Abdul Majeed, M.D.

Abdul Majeed, M.D.

Majeed is a hematologist, consultant, FRCP London, and a pioneer in stem cell transplantation and stem cell therapies in Iraq. He heads Global Stem Cells Group affiliate Stem Cell Centre in Baghdad. In 1992, he obtained a degree from the Board of Internal Medicine and served as the head of the medicine department Bin Majid hospital in Basra, southern Iraq.

In 2004, Majeed invited Prof. Marino Andolina (a pediatric immunologist from Trieste Italy) to Baghdad to perform the first autologous bone marrow transplant in Iraq. In 2009, Majeed and his team in Iraq began providing bone marrow-derived stem cell therapy for spinal cord injuries, multiple sclerosis, muscular dystrophy, and other medical conditions. He served as director of the bone marrow transplantation unit at the medical city hospital in Baghdad from 2011 to 2017.

Hilmi Karadeniz, M.D.

Hilmi Karadeniz, M.D.

Karadeniz specializes in orthopedics and traumatology including sports medicine and surgery, arthroplasty, trauma surgery, spinal surgery, and ultrasound-guided PRP applications.

He studied at Istanbul School of Medicine, Istanbul University from 1998 – 2004, and Orthopedics and Traumatology Clinic II, Istanbul Research and Training Hospital, Ministry of Health from 2005 – 2011. Karadeniz currently serves as an orthopedic surgeon and traumatologist at Şişli Kolan Hospital in Istanbul.

The Istanbul international symposium is part of ISSCA’s mission to support a paradigm shift from traditional healthcare solutions to regenerative medicine and provide the latest innovative discoveries and developments in all areas of stem cell research. The symposium will host a group of renowned international speakers, experts in the field of stem cell and regenerative medicine, who will provide a full day of rigorous scientific discourse directed to physicians.

The day’s events will incorporate information on stem cell biology, medicine, applications, regulations, product development, and commercialization, business opportunities, challenges, and potential strategies for overcoming those challenges.

To participate in the ISSCA Istanbul Symposium, reserve your spot by registering today. For more information, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.

About International Society for Stem Cell Application (ISSCA):

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

###

 

Abdul Majeed, M.D. and Hilmi Karadeniz, M.D.

Daeyong Kim, Ph.D., and Syed Salman Naeem Gilani, M.D.

 

 

 

 

 

 

 

ISSCA Istanbul conference: The International Association for Stem Cell Application (ISSCA) has announced plans to host a regenerative medicine symposium at the Hotel Hyatt Regency in Istanbul, Turkey April 28, 2018.

MIAMI, Feb 19, 2018—The International Association for Stem Cell Application (ISSCA) will host its next regenerative medicine symposium at the Hotel Hyatt Regency in Istanbul, Turkey April 28, 2018.

The symposium agenda will focus on:

  • Molecular biology
  • Clinical advances in stem cell research
  • Models of treatment in surgical and cosmetic applications, and in clinical conditions
  • Technological advances
  • Application of minimally manipulated stem cells in the physician’s office
  • Stem cells, regenerative medicine and its application in anti-aging medicine, Pain Management and Orthopedics
  • Medical legal issues.
  • Regulatory Pathways

Istanbul, the economic, cultural, and historic center of Turkey, is the country’s most populous city. The luxurious Hotel Hyatt Regency, located near Istanbul’s Ataturk Airport, offers visitors the combination of comfort, culture, and convenience for exploring the ancient city. Symposium attendees will be able to discover sights such as the Blue Mosque and the Hagia Sophia.

The Istanbul international symposium is part of ISSCA’s mission to support a paradigm shift from traditional healthcare solutions to regenerative medicine, and provide the latest innovative discoveries and developments in all areas of stem cell research. The symposium will host a group of renowned international speakers, experts in the field of stem cell and regenerative medicine, who will provide a full day of rigorous scientific discourse directed to physicians.

The day’s events will incorporate information on stem cell biology, medicine, applications, regulations, product development, and commercialization, business opportunities, challenges, and potential strategies for overcoming those challenges.

To participate in the ISSCA Istanbul Symposium, reserve your spot by registering today.

For more information, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.

About International Society for Stem Cells Applications

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

###

ISSCA Istanbul conference

 

 

 

 

 

 

 

 

MIAMI, Feb 19, 2018—Leslie Mesen, M.D., a leader in the field of anti-aging medicine in Latin America and medical director of Global Stem Cells Group affiliate Stem Cell Center in Escazu, Costa Rica, will be a keynote speaker at the International Association for Stem Cell Application (ISSCA) Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey April 28, 2018.

ISSCA Leslie Mesen

Leslie Mesen, M.D.

Mesen will present a lecture detailing the wound-healing potential of mesenchymal stem cell procedures—both SVF and BMAC—in wounds when no other treatment options exist. Mesen will discuss his experience successfully treating a serious foot wound using mesenchymal stem cells in a 45-year-old patient. The wound was the result of a 30.000-volt shock caused when the patient came in contact with a high-tension power line. The shock traveled down the patient’s leg and exited through his left foot, leaving the wound and underlying structure exposed.

Three months post-injury, the patient’s foot wound was not healing. Mesen administered an SVF autologous stem cell procedure and, four-weeks post-stem cell treatment, the wound showed significant improvement (70 percent wound closure) with clear new tissue growth visible around the wound. Mesen then performed an activated PRP procedure to further stimulate cell division.

Two weeks after the PRP treatment, the patient was walking in shoes, and underwent a final stem cell procedure. Over a period of five weeks, the patient—an electrician– recovered the ability to care for himself. He is expected to return to work soon.

Mesen is board certified in anti-aging and regenerative medicine by The American Academy of Anti-Aging Medicine and a pioneer in anti-aging medicine in Latin America.

He has extensive experience as the chief medical officer of three highly recognized anti-aging institutes: Costagenics Age Management program (2007-2010), Anti-Aging Institute of the Americas (2010-2013) and the Anti-Aging and Wellness Clinic (2014- present).

Mesen studied medicine at Universidad Iberoamericana (UNIBE) in San José, Costa Rica and receives continuing education courses in the United States and Latin America. In the U.S., he has trained at the University of Miami Jackson Memorial Hospital. His range of services encompass all aspects of aging, delivering programs tailored to each patient’s unique needs. Mesen offers platelet-rich plasma (PRP) therapy, HRT, hair regrowth treatments, intravenous infusions, and a range of other anti-aging and aesthetic treatments.

The Istanbul international symposium is part of ISSCA’s mission to support a paradigm shift from traditional healthcare solutions to regenerative medicine and provide the latest innovative discoveries and developments in all areas of stem cell research. The symposium will host a group of renowned international speakers, experts in the field of stem cell and regenerative medicine, who will provide a full day of rigorous scientific discourse directed to physicians.

The day’s events will incorporate information on stem cell biology, medicine, applications, regulations, product development, and commercialization, business opportunities, challenges, and potential strategies for overcoming those challenges.

To participate in the ISSCA Istanbul Symposium, reserve your spot by registering today.

For more information, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.

About International Society for Stem Cell Application (ISSCA):

The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine

and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

###

ISSCA Leslie Mesen

 

 

 

 

 

 

 

 

 

(Image: Istanbul, Turkey)

The International Association for Stem Cell Application (ISSCA) has announced plans to host a regenerative medicine symposium in Istanbul, Turkey April 28, 2018.

MIAMI, Feb 14, 2018—The International Association for Stem Cell Application (ISSCA) has announced plans to host a regenerative medicine symposium in Istanbul, Turkey April 28, 2018. The symposium will focus on new advances in cell therapies.

The Istanbul international symposium is part of ISSCA’s mission to support a shift from traditional healthcare solutions to regenerative medicine and provide the latest innovative discoveries and developments in all areas of stem cell research. The symposium will host a group of renowned international speakers, experts in the field of stem cell and regenerative medicine, who will provide a full day of rigorous scientific discourse directed to physicians.

The day’s events will incorporate information on stem cell biology, medicine, applications, regulations, product development, and commercialization, business opportunities, challenges, and potential strategies for overcoming those challenges.

To learn more about the ISSCA symposium in Istanbul and to register to attend, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.

About International Society for Stem Cells Applications

ISSCA 2018 training agendaThe International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.

The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.

As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.

Regenerative Medicine symposium Istanbul